SINONASAL CARCINOMA
Clinical trials for SINONASAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shrink untreatable sinus tumors enough for surgery
Disease control Recruiting nowThis study tests whether combining two drugs (becotatug vedotin and epirubicin) can shrink a rare type of sinus cancer that has come back and cannot be removed with surgery. About 40 adults with EGFR-positive tumors will receive the treatment to see if it makes the cancer small e…
Matched conditions: SINONASAL CARCINOMA
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New chemo strategy may spare sinus cancer patients from major surgery
Disease control Recruiting nowThis study tests a new approach for a rare sinus cancer that often spreads along nerves. About 100 adults with advanced tumors will receive three sessions of targeted chemotherapy directly into the tumor's blood supply. If the tumor disappears on scans, patients may avoid surgery…
Matched conditions: SINONASAL CARCINOMA
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New study follows sinonasal cancer patients to learn how treatments affect survival and daily life
Knowledge-focused Recruiting nowThis study follows 200 people with sinonasal cancer to see how well treatments work and how they affect quality of life. Researchers will also analyze tumor tissue to learn about the genetic changes that drive this cancer. The goal is to better understand the disease and improve …
Matched conditions: SINONASAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC